Vanguard Group’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2.07K | Hold |
|
|||||
|
2023
Q4 | $12.2K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $6.67K | Hold |
|
|||||
|
2023
Q1 | $26.5K | Sell |
|
|||||
|
2022
Q4 | $170K | Sell |
|
|||||
|
2022
Q3 | $668K | Hold |
|
|||||
|
2022
Q2 | $1.26M | Hold |
|
|||||
|
2022
Q1 | $2.43M | Sell |
|
|||||
|
2021
Q4 | $2.69M | Sell |
|
|||||
|
2021
Q3 | $4.46M | Hold |
|
|||||
|
2021
Q2 | $4.87M | Sell |
|
|||||
|
2021
Q1 | $6.18M | Buy |
|
|||||
|
2020
Q4 | $537K | Buy |
|
|||||
|
2020
Q3 | $213K | Sell |
|
|||||
|
2020
Q2 | $468K | Buy |
|
|||||
|
2020
Q1 | $365K | Sell |
|
|||||
|
2019
Q4 | $540K | Sell |
|
|||||
|
2019
Q3 | $930K | Buy |
|
|||||
|
2019
Q2 | $1.41M | Buy |
|
|||||
|
2019
Q1 | $388K | Buy |
|
|||||
|
2018
Q4 | $125K | Sell |
|
|||||
|
2018
Q3 | $768K | Buy |
|
|||||
|
2018
Q2 | $356K | Buy |
|
|||||
|
2018
Q1 | $595K | Buy |
|
|||||
|
2017
Q4 | $554K | Buy |
|
|||||
|
2017
Q3 | $774K | Sell |
|
|||||
|
2017
Q2 | $1.46M | Sell |
|
|||||
|
2017
Q1 | $2.14M | Buy |
|
|||||
|
2016
Q4 | $2.21M | Sell |
|
|||||
|
2016
Q3 | $2.79M | Hold |
|
|||||
|
2016
Q2 | $1.87M | Hold |
|
|||||
|
2016
Q1 | $2.09M | Hold |
|
|||||
|
2015
Q4 | $1.34M | Buy |
|
|||||
|
2015
Q3 | $1.36M | Hold |
|
|||||
|
2015
Q2 | $2.63M | Buy |
|
|||||
|
2015
Q1 | $3M | Buy |
|
|||||
|
2014
Q4 | $3.85M | Buy |
|
|||||
|
2014
Q3 | $3.5M | Buy |
|
|||||
|
2014
Q2 | $2.93M | Sell |
|
|||||
|
2014
Q1 | $3.32M | Buy |
|
|||||
|
2013
Q4 | $3.73M | Buy |
|
|||||
|
2013
Q3 | $2.49M | Buy |
|
|||||
|
2013
Q2 | $4.41M | Buy |
|